What You Should Know:
– Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today announced the acquisition of Verosint, a leader in Identity Threat Detection and Response (ITDR) solutions.
– The acquisition represents Imprivata’s latest strategic investment in modernizing enterprise access management with solutions that deliver advanced, frictionless, and passwordless access for every user type, including frontline staff, knowledge workers, and third-party identities, while strengthening security, streamlining compliance, and reducing total cost of ownership.
Imprivata Acquires Verosint to Advance AI-Powered, Passwordless Access Security
Imprivata, a leader in secure access management for healthcare and other mission-critical industries, has announced the acquisition of Verosint, an identity threat detection and response (ITDR) innovator. The move enhances Imprivata’s mission to deliver frictionless yet secure access across clinical and enterprise environments—ensuring that every second of essential work remains efficient, protected, and compliant.
Imprivata’s unified platform enables organizations to manage and secure both enterprise and third-party identities, streamline access, and mitigate internal and external threats while lowering total cost of ownership.
“Understanding risk is an essential component of a modern access management solution, and this acquisition allows us to deliver greater value to our customers at a faster pace,” said Fran Rosch, CEO of Imprivata. “By integrating Verosint’s AI-powered risk engine into our platform, we advance our broader vision of a comprehensive, passwordless access ecosystem. Imprivata has already introduced the industry’s first passwordless, zero-trust solution for shared device access purpose-built for frontline workers. With Verosint, our platform will continuously validate that every access request is appropriate and authorized—enhancing productivity, security, and cost efficiency.”
The integration of Verosint’s ITDR technology fortifies Imprivata’s frontline security framework by continuously monitoring for unusual behaviors, validating workflow integrity, and automating adaptive responses. Through advanced risk intelligence, multi-factor authentication options, and workflow-aware automation, the combined platform protects identity infrastructures that healthcare teams depend on every day.
Core ITDR Capabilities Now Powering Imprivata’s Platform:
- AI-driven continuous risk assessment to detect anomalies and prevent breaches proactively
- Automated response mechanisms to block, challenge, or escalate authentication when risk is detected
- Comprehensive identity intelligence for strengthened enterprise-wide access protection
Pioneering a Passwordless, Zero-Trust Future
The acquisition also advances Imprivata’s roadmap toward next-generation, passwordless access at enterprise scale. Key initiatives include:
- FIDO passkey and facial authentication integration to enhance security while simplifying user experience
- Operational analytics delivering near real-time insights into access patterns and workflow optimization
- Universal authentication support across cloud, SaaS, and legacy systems to ensure seamless interoperability
- Personalized access experiences on shared devices to optimize productivity for frontline and mobile workers
Together, Imprivata and Verosint are redefining identity and access management with a secure, intelligent, and unified platform designed for the modern digital healthcare enterprise.
